The Ireland-based company Perrigo, the world’s largest manufacturer of OTC products and supplier of infant formulas, has announced a deal through which it will acquire well-known OTC brands from GSK. The acquisitions include the NiQuitin nicotine replacement therapy (NRT) business, primarily in the European Economic Area (EEA) and Brazil; Novartis’s legacy Australian NRT business, including the Nicotinell brand; several assorted OTC brands including Coldrex across the EEA, and Panodil, Nezeril, …